262 related articles for article (PubMed ID: 23263355)
21. Retinal morphological and functional response to Idebenone therapy in Leber hereditary optic neuropathy.
Mercuţ MF; Tănasie CA; Dan AO; Nicolcescu AM; Ică OM; Mocanu CL; Ştefănescu-Dima AŞ
Rom J Morphol Embryol; 2022; 63(1):213-219. PubMed ID: 36074687
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of treatment with idebenone in Leber's hereditary optic neuropathy in the Netherlands: A national cohort study.
van Everdingen JAM; Pott JWR; Bauer NJC; Krijnen AM; Lushchyk T; Wubbels RJ
Acta Ophthalmol; 2022 Sep; 100(6):700-706. PubMed ID: 35394113
[TBL] [Abstract][Full Text] [Related]
23. Colour vision defects in asymptomatic carriers of the Leber's hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study.
Quiros PA; Torres RJ; Salomao S; Berezovsky A; Carelli V; Sherman J; Sadun F; De Negri A; Belfort R; Sadun AA
Br J Ophthalmol; 2006 Feb; 90(2):150-3. PubMed ID: 16424523
[TBL] [Abstract][Full Text] [Related]
24. Leber's hereditary optic neuropathy: course of disease in consideration of idebenone treatment and type of mutation.
Tonagel F; Wilhelm H; Richter P; Kelbsch C
Graefes Arch Clin Exp Ophthalmol; 2021 Apr; 259(4):1009-1013. PubMed ID: 33337510
[TBL] [Abstract][Full Text] [Related]
25. [A teenager with acute bilateral visual loss].
Ødegaard EM; Jørstad ØK; Kerty E
Tidsskr Nor Laegeforen; 2018 Aug; 138(12):. PubMed ID: 30132618
[TBL] [Abstract][Full Text] [Related]
26. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy.
Sadun AA; Chicani CF; Ross-Cisneros FN; Barboni P; Thoolen M; Shrader WD; Kubis K; Carelli V; Miller G
Arch Neurol; 2012 Mar; 69(3):331-8. PubMed ID: 22410442
[TBL] [Abstract][Full Text] [Related]
27. International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy.
Carelli V; Carbonelli M; de Coo IF; Kawasaki A; Klopstock T; Lagrèze WA; La Morgia C; Newman NJ; Orssaud C; Pott JWR; Sadun AA; van Everdingen J; Vignal-Clermont C; Votruba M; Yu-Wai-Man P; Barboni P
J Neuroophthalmol; 2017 Dec; 37(4):371-381. PubMed ID: 28991104
[TBL] [Abstract][Full Text] [Related]
28. Idebenone treatment in Leber's hereditary optic neuropathy.
Carelli V; La Morgia C; Valentino ML; Rizzo G; Carbonelli M; De Negri AM; Sadun F; Carta A; Guerriero S; Simonelli F; Sadun AA; Aggarwal D; Liguori R; Avoni P; Baruzzi A; Zeviani M; Montagna P; Barboni P
Brain; 2011 Sep; 134(Pt 9):e188. PubMed ID: 21810891
[No Abstract] [Full Text] [Related]
29. Rapid visual recovery after coenzyme q10 treatment of leber hereditary optic neuropathy.
Huang CC; Kuo HC; Chu CC; Kao LY
J Neuroophthalmol; 2002 Mar; 22(1):66. PubMed ID: 11937918
[No Abstract] [Full Text] [Related]
30. Idebenone in Friedreich ataxia and Leber's hereditary optic neuropathy: close mechanisms, similar therapy?
Schiff M; Rustin P
Brain; 2016 Jul; 139(Pt 7):e39. PubMed ID: 27095078
[No Abstract] [Full Text] [Related]
31. Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy.
Yu-Wai-Man P; Soiferman D; Moore DG; Burté F; Saada A
Mitochondrion; 2017 Sep; 36():36-42. PubMed ID: 28093355
[TBL] [Abstract][Full Text] [Related]
32. Leber hereditary optic neuropathy: new and emerging therapies.
Davila-Siliezar P; Carter M; Milea D; Lee AG
Curr Opin Ophthalmol; 2022 Nov; 33(6):574-578. PubMed ID: 36066375
[TBL] [Abstract][Full Text] [Related]
33. Assessing the Treatment Effect of Idebenone in Leber Hereditary Optic Neuropathy Requires Appropriate Study Designs.
Finsterer J
J Neuroophthalmol; 2023 Sep; 43(3):e95-e96. PubMed ID: 34314394
[No Abstract] [Full Text] [Related]
34. Age-dependent retinal neuroaxonal degeneration in children and adolescents with Leber hereditary optic neuropathy under idebenone therapy.
Schworm B; Siedlecki J; Catarino C; von Livonius B; Muth DR; Rudolph G; Havla J; Klopstock T; Priglinger C
Eur J Neurol; 2023 Aug; 30(8):2525-2533. PubMed ID: 37158303
[TBL] [Abstract][Full Text] [Related]
35. [CIinical study on treatment of Leber hereditary optic neuropathy].
Li CW; Zhuang ZY; Zhang SK
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Dec; 29(12):1078-80. PubMed ID: 20214326
[TBL] [Abstract][Full Text] [Related]
36. [New treatment option for Leber hereditary optic neuropathy: early diagnosis is required].
van Everdingen JAM; Tjon-Fo-Sang M; van den Born LI; Pott JWR
Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854587
[TBL] [Abstract][Full Text] [Related]
37. [Leber's Hereditary Optic Neuropathy].
Priglinger C; Klopstock T; Rudolph G; Priglinger SG
Klin Monbl Augenheilkd; 2019 Nov; 236(11):1271-1282. PubMed ID: 31639883
[TBL] [Abstract][Full Text] [Related]
38. Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy-Response to Dr. Finsterer's Letter.
Catarino CB; von Livonius B; Priglinger C; Landau K; Newman NJ; Votruba M; Rudolph G; Klopstock T
J Neuroophthalmol; 2023 Sep; 43(3):e96. PubMed ID: 34387631
[No Abstract] [Full Text] [Related]
39. A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency.
Garip Kuebler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Rudolph G; Hintschich C
Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3421-3426. PubMed ID: 34159407
[TBL] [Abstract][Full Text] [Related]
40. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial.
Newman NJ; Biousse V; Newman SA; Bhatti MT; Hamilton SR; Farris BK; Lesser RL; Turbin RE
Am J Ophthalmol; 2006 Jun; 141(6):1061-1067. PubMed ID: 16765674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
